It has been speculated that, as seen in tuberculosis, human immunodeficiency virus (HIV) and Mycobacterium leprae (M. leprae) co-infection may exacerbate the pathogenesis of leprosy lesions and/or lead to increased susceptibility to leprosy. However, to date, HIV infection has not appeared to increase susceptibility to leprosy. In contrast, initiation of antiretroviral treatment (ART) has been reported to be associated with anecdotal activation of M. leprae infection and exacerbation of existing leprosy lesions.
To determine whether ART is associated with worsening of the manifestations of leprosy, a cohort of leprosy patients recruited between 1996 and 2006 at the Oswaldo Cruz Foundation (FIOCRUZ) Leprosy Outpatient Clinic in Rio de Janeiro, Brazil, was studied longitudinally. ART treatment of HIV/leprosy co-infection was associated with the tuberculoid type, paucibacillary disease, and lower bacillary loads. CD4 lymphocyte counts were higher among HIV/leprosy patients at the time of leprosy diagnosis, while viral loads were lower compared with the time of HIV diagnosis. The conclusion was that ART and immune reconstitution were critical factors driving the development and/or clinical appearance of leprosy lesions.
References
1.
Global leprosy situation. Wkly Epidemiol Rec2000;82:225–32.
2.
Becx-BleuminkMBerheD.Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All-Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis1992;60:173–84.
3.
BwireRKawumaHJ. Type 1 reactions in leprosy, neuritis and steroid therapy: The impact of the human immunodeficiency virus. Trans R Soc Trop Med Hyg1994;88:315–6.
4.
NeryJAVieiraLMde MatosHJGalloMESarnoEN. Reactional states in multibacillary Hansen disease patients during multidrug therapy. Rev Inst Med Trop Sao Paulo1998;40:363–70.
5.
BrittonWJLockwoodDN. Leprosy reactions: Current and future approaches to management. Baillière's Clin Infect Dis1997;4:1–23.
World Health Organization. Leprosy today [cited 2007 Nov 26]. Available from: URL: http://www.who.int/lep/en.
8.
ShelburneSA3rdHamillRJ. The immune reconstitution inflammatory syndrome. AIDS Rev2003;5:67–79.
9.
SampaioEPCaneshiJRTNeryJADuppreNCPereiraGMVieiraLM, Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun1995;63:1848–54.
10.
LawnSDWoodCLockwoodDN. Borderline tuberculoid leprosy: An immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis2003;36:e5–6.
11.
CouppiePAbelSVoinchetHRousselMHelenonRHuerreM, Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol2004;140:997–1000.
Ministério da Saúde. Boletim Epidemiológico AIDS/DST, ano III, no. 1. Brazil, 2007.
14.
RidleyDSJoplingWH. Classification of leprosy according to immunity: A five-group system. Int J Lepr Other Mycobact Dis1966;34:255–73.
15.
JardimMRAntunesSLWildenbeestJGNeryJAIllarramendiXMoraesMO, PGL-I as an accessory test for the diagnosis of pure neural leprosy. Lepr Rev2005;76:232–40.
16.
Guia de Vigilância Epidemiológica, 5th ed. Brasilia: Fundação Nacional de Saúde; 2002.
17.
Ministério da Saúde. Portaria No. 59. 2003 Jan 28. Edição No. 22. 2003 Jan 30. anexo II. Procedimientos seqüenciados para detecção de anticorpos anti-HIV em indivíduos com idade acima de dois anos.
18.
SPSS Inc.SPSS for Windows: Version 11.0. Chicago: SPSS Inc.; 2003.
19.
MastroianniCMLichtnerMMengoniFD'AgostinoCForcinaGd'EttorreG, Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS1999;13:883–90.
20.
SingalAMehtaSPandhiD.Immune reconstitution inflammatory syndrome in an HIV seropositive leprosy patient. Lepr Rev2006;77:76–80.
21.
AndradeVLAlvesT MoreiraAvelleiraJC RegazziBayonaM.Prevalence of HIV-1 in leprosy patients in Rio de Janeiro, Brazil. Acta Leprol1997;10:159–63.
22.
LedermanHMWilliamsPLWuJWEvansTGCohnSEMcCutchanJA, Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis2003;188:1794–803.
23.
JacobMGeorgeSPulimoodSNathanN.Short-term follow-up of patients with multibacillary leprosy and HIV infection. Int J Lepr Other Mycobact Dis1996;64:392–5.
24.
GebreSSaundersonTMesseleTByassP.The effect of HIV status on the clinical picture of leprosy: A prospective study in Ethiopia. Lepr Rev2000;71:338–43.
25.
UstianowskiAPLawnSDLockwoodDN. Interactions between HIV infection and leprosy: A paradox. Lancet Infect Dis2006;6: 350–60.
26.
BorgdorffMWvan den BroekJChumHJKlokkeAHGrafPBarongoLR, HIV-1 infection as a risk factor for leprosy: A case-control study in Tanzania. Int J Lepr Other Mycobact Dis1993;61:556–62.
27.
KawumaHJBwireRAdatu-EngwauF.Leprosy and infection with the human immunodeficiency virus in Uganda: A case-control study. Int J Lepr Other Mycobact Dis1994;62:521–6.
28.
LienhardtCKamateBJametPTounkaraAFayeOCSowSO, Effect of HIV infection on leprosy: A three-year survey in Bamako, Mali. Int J Lepr Other Mycobact Dis1996;64:383–91.
29.
PalellaFJJrDelaneyKMMoormanACLovelessMOFuhrerJSattenGA, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med1998;338:853–60.
30.
LangeCGValdezHMedvikKAsaadRLedermanMM. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin Immunol2002;102:154–61.
31.
KrahenbuhlJLAdamsLB. Mycobacterium leprae as an opportunistic pathogen. In: ParadiseLJ, editor. Opportunistic intracellular bacteria and immunity. New York: Plenum Press; 1999. p. 75–89.
32.
TrindadeMAManiniMIMasettiJHLeiteMATakahashiMDNaafsB.Leprosy and HIV co-infection in five patients. Lepr Rev2005;76:162–6.
33.
MachadoPDavidYPedrosoCBrutesCBarralABarral-NettoM.Leprosy and HIV infection in Bahia, Brazil. Int J Lepr Other Mycobact Dis1998;66:227–9.
